-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
RikoSoPPphhv0H2f2vNx7A8mMCObgLIK6MxyXhRza3HNl5YTyP9pCabz+WzQ343Q
4C3GCswW5atAhGIPCPuw2g==
SECURITIES AND EXCHANGE COMMISSION FORM 10-Q (MARK ONE) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-08185 CHEMICAL FINANCIAL CORPORATION Michigan 38-2022454 333 East Main Street (989) 839-5350 Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes X No Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes X No The number of shares outstanding of the Registrant's Common Stock, $1 par value, as of April 30, 2004, was 23,934,027 shares. INDEX Page FORWARD-LOOKING STATEMENTS 3 PART I. FINANCIAL INFORMATION Item 1. Financial Statements (unaudited, except Consolidated Consolidated Statements of Income for the Three Months Ended Consolidated Statements of Financial Position as of March 31, 2004, Consolidated Statements of Cash Flows for the Three Months Ended Notes to Consolidated Financial Statements 7-15 Item 2. Management's Discussion and Analysis of Financial Condition and Item 3. Quantitative and Qualitative Disclosures About Market Risk 23 Item 4. Controls and Procedures 23 PART II. OTHER INFORMATION Item 2. Changes in Securities, Use of Proceeds and Issuer Purchases Item 6. Exhibits and Reports on Form 8-K 24 SIGNATURES 25 FORWARD-LOOKING STATEMENTS This report contains forward-looking statements that are based on management's beliefs, assumptions, current expectations, estimates and projections about the financial services industry, the economy, and the Corporation itself. Words such as "anticipates," "believes," "estimates," "judgment," "expects," "forecasts," "intends," "is likely," "plans," "predicts," "projects," "should," "will" and variations of such words and similar expressions are intended to identify such forward-looking statements. In addition, all statements under Part I, Item 3 concerning quantitative and qualitative disclosures about market risk are forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions ("risk factors") that are difficult to predict with regard to timing, extent, likelihood and degree of occurrence. Therefore, actual results and outcomes may materially differ from what may be expressed or forecasted in such forward-looking statement
s. The Corporation undertakes no obligation to update, amend or clarify forward-looking statements, whether as a result of new information, future events or otherwise. Risk Factors include, but are not limited to, changes in interest rates and interest rate relationships; demand for products and services; the degree of competition by traditional and non-traditional competitors; changes in banking laws and regulations; changes in tax laws; changes in prices, levies and assessments; the impact of technological advances and issues; governmental and regulatory policy changes; the outcomes of pending and future litigation and contingencies; trends in customer behavior as well as their ability to repay loans; changes in the local and national economy; opportunities for acquisition and the effective completion of acquisitions and integration of acquired entities; and the local and global effects of the ongoing war on terrorism and other military actions, including actions in Iraq. These are representative of the risk factors that could cause a difference between an ultimate actual outcome and a preceding forward-looking statement. PART I. FINANCIAL INFORMATION ITEM 1. FINANCIAL STATEMENTS CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES Three Months Ended 2004 2003 (In thousands, except per share data) INTEREST INCOME Interest and fees on loans $ 37,478 $ 36,414 Interest on investment securities: Taxable 8,876 10,680 Tax-exempt 565 677 Total interest on securities 9,441 11,357 Interest on federal funds sold 201 336 Interest on deposits with unaffiliated banks 77 139 TOTAL INTEREST INCOME 47,197 48,246 INTEREST EXPENSE Interest on deposits 7,703 10,840 Interest on FHLB borrowings 2,576 2,113 Interest on other borrowings - short term 96 169 TOTAL INTEREST EXPENSE 10,375 13,122 NET INTEREST INCOME 36,822 35,124 Provision for loan losses 746 295 NET INTEREST INCOME after provision for loan losses 36,076 34,829 NONINTEREST INCOME Services charges on deposit accounts 4,554 3,891 Trust services revenue 1,909 1,727 Other charges and fees for customer services 1,548 1,915 Mortgage banking revenue 780 1,547 Investment securities gains 983 184 Other 188 50 TOTAL NONINTEREST INCOME 9,962 9,314 OPERATING EXPENSES Salaries, wages and employee benefits 14,801 13,689 Occupancy 2,459 1,964 Equipment 2,385 2,049 Other 5,515 5,324 TOTAL OPERATING EXPENSES 25,160 23,026 INCOME BEFORE INCOME TAXES 20,878 21,117 Federal income taxes 6,759 7,103 NET INCOME $ 14,119 $ 14,014 NET INCOME PER SHARE (Basic) $ .59 $ .59 (Diluted) $ .59 $ .59 Cash dividends per share $ .265 $ .25 See accompanying notes to consolidated financial statements CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES March 31, December 31, March 31, (Unaudited) (Unaudited) ASSETS Cash and demand deposits due from banks $ 106,610 $ 131,184 $ 114,023 Federal funds sold 75,400 25,900 32,400 Interest bearing deposits with unaffiliated banks 27,854 5,107 18,674 Investment securities: Available for sale (at estimated market value) 840,957 728,499 946,711 Held to maturity (estimated market value - $174,133 at Total investment securities 1,010,699 921,862 1,223,078 Loans: Commercial 444,229 405,929 325,673 Real estate construction 148,592 138,280 106,384 Real estate commercial 640,292 628,815 506,243 Real estate residential 773,195 767,199 691,626 Consumer 542,811 541,052 501,767 Total loans 2,549,119 2,481,275 2,131,693 Less: Allowance for loan losses 33,494 33,179 30,693 Net loans 2,515,625 2,448,096 2,101,000 Premises and equipment 48,669 49,616 41,841 Intangible assets 76,141 76,846 40,060 Other assets 49,574 50,277 42,423 TOTAL ASSETS $ 3,910,572 $ 3,708,888 $ 3,613,499 LIABILITIES AND SHAREHOLDERS' EQUITY Deposits: Noninterest-bearing $ 502,147 $ 532,752 $ 448,585 Interest-bearing 2,515,476 2,434,484 2,455,517 Total deposits 3,017,623 2,967,236 2,904,102 FHLB borrowings 292,210 155,373 153,591 Other borrowings - short term 92,002 91,524 83,348 Interest payable and other liabilities 38,940 36,706 35,418 Total liabilities 3,440,775 3,250,839 3,176,459 Shareholders' equity: Common stock, $1 par value: Authorized - 30,000 shares Issued and outstanding - 23,931 shares, 23,801 shares, and 23,690 shares, respectively 23,931 23,801 23,690 Surplus 333,065 328,774 325,096 Retained earnings 102,530 94,746 70,812 Accumulated other comprehensive income 10,271 10,728 17,442 Total shareholders' equity 469,797 458,049 437,040 TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $ 3,910,572 $ 3,708,888 $ 3,613,499 See accompanying notes to consolidated financial statements. CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES Three Months Ended 2004 2003 (In thousands) CASH FLOWS FROM OPERATING ACTIVITIES: Net income $ 14,119 $ 14,014 Adjustments to reconcile net income to net cash provided by operating activities: Provision for loan losses 746 295 Gains on sales of loans (481 ) (1,314 ) Proceeds from sales of loans 37,997 94,736 Loans originated for sale (37,747 ) (85,825 ) Investment securities gains (983 ) (184 ) Provision for depreciation and amortization 2,513 2,183 Net amortization of investment securities 2,519 2,565 Net decrease in accrued income and other assets 2,650 861 Net increase in interest payable and other liabilities 4,133 5,741 Net Cash Provided by Operating Activities 25,466 33,072 CASH FLOWS FROM INVESTING ACTIVITIES: Securities available for sale: Proceeds from maturities, calls and principal reductions 44,037 86,892 Proceeds from sales 54,827 8,489 Purchases (213,267 ) (188,536 ) Securities held to maturity: Proceeds from maturities, calls and principal reductions 31,511 48,997 Purchases (8,198 ) (55,385 ) Net increase in loans (69,765 ) (65,190 ) Purchases of premises and equipment (827 ) (583 ) Net Cash Used in Investing Activities (161,682 ) (165,316 ) CASH FLOWS FROM FINANCING ACTIVITIES: Net increase in demand deposits, NOW accounts and savings accounts 58,478 87,061 Net decrease in certificates of deposit and other time deposits (8,091 ) (30,231 ) Net increase (decrease) in other borrowings - short term 478 (20,864 ) Proceeds from FHLB borrowings 150,000 - Principal payments on FHLB borrowings (13,163 ) (3,802 ) Cash dividends paid (6,338 ) (5,925 ) Proceeds from shares issued 2,525 451 Repurchases of common stock - (496 ) Net Cash Provided by Financing Activities 183,889 26,194 Net Increase (Decrease) in Cash and Cash Equivalents 47,673 (106,050 ) Cash and cash equivalents at beginning of year 162,191 271,147 Cash and Cash Equivalents at End of Period $ 209,864 $ 165,097 Supplemental disclosure of cash flow information: Interest paid on deposits, FHLB borrowings and other borrowings - short-term $ 10,196 $ 12,934 See accompanying notes to consolidated financial statements. CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES NOTE A: BASIS OF PRESENTATION The accompanying unaudited consolidated financial statements of Chemical Financial Corporation (the "Corporation") have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, the accompanying unaudited consolidated financial statements contain all adjustments (consisting only of normal recurring accruals) necessary to present fairly the financial condition and results of operations of the Corporation for the periods presented. Operating results for the three months ended March 31, 2004 are not necessarily indicative of the results that may be expected for the year ending December 31, 2004. For further information, refer to the consolidated financial statements
and footnotes thereto included in the Corporation's Annual Report on Form 10-K for the year ended December 31, 2003. Certain prior year amounts have been reclassified to place them on a basis comparable with the current period's financial statements. Earnings Per Share All earnings per share amounts have been presented to conform to the requirements of Statement of Financial Accounting Standards No. 128, "Earnings Per Share." Basic earnings per share exclude any dilutive effect of stock options. Basic earnings per share for the Corporation is computed by dividing net income by the weighted average number of common shares outstanding. Diluted earnings per share for the Corporation is computed by dividing net income by the sum of the weighted average number of common shares outstanding and the dilutive effect of outstanding employee stock options. CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES Earnings Per Share (continued) The following table summarizes the number of shares used in the numerator and denominator of the basic and diluted earnings per share computations: Three Months Ended 2004 2003 (In thousands) Numerator for both basic and diluted earnings per share, net income $14,119 $14,014 Denominator for basic earnings per share, average outstanding common shares 23,892 23,696 Potential dilutive shares resulting from employee stock options 94 44 Denominator for diluted earnings per share 23,986 23,740 Comprehensive Income The components of comprehensive income, net of related tax, for the three months ended March 31, 2004 and 2003 are as follows (in thousands of dollars): Three Months Ended 2004 2003 Net income $14,119 $14,014 Change in unrealized net gains on investment securities available for sale, net of tax (457 ) (1,343 ) Comprehensive income $13,662 $12,671 CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES Comprehensive Income (continued) The components of accumulated other comprehensive income, net of related tax, at March 31, 2004, December 31, 2003 and March 31, 2003 are as follows (in thousands of dollars): March 31, December 31, March 31, Unrealized net gains on investment securities available for sale (net of related tax of $5,531 Accumulated other comprehensive income $10,271 $10,728 $17,442 Operating Segment Under the provisions of Statement of Financial Accounting Standards No. 131, "Disclosures about Segments of an Enterprise and Related Information," it is management's opinion that the Corporation operates in a single operating segment - commercial banking. The Corporation is a bank holding company that operated four commercial banks, a title insurance company and a property and casualty insurance company, each as a separate subsidiary of the Corporation, as of March 31, 2004. The Corporation's commercial bank subsidiaries operate as community banks and offer a full range of commercial banking and fiduciary products and services to the residents and business customers in their geographical market areas. The products and services offered by the commercial bank subsidiaries are generally consistent throughout the Corporation. Each of the Corporation's commercial bank subsidiaries operates within the state of Michigan. The marketing of products and services throughout the Corporation's subsidiary banks is gen
erally uniform, as many of the markets served by the subsidiaries overlap. The distribution of products and services is uniform throughout the Corporation's commercial bank subsidiaries and is achieved primarily through retail branch banking offices, automated teller machines and electronically accessed banking products. The commercial bank subsidiaries are state-chartered commercial banks and operate under the same banking regulations. CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES Goodwill During 2002, the Corporation adopted Statement of Financial Accounting Standards No. 142, "Goodwill and Other Intangible Assets" (SFAS 142). Under SFAS 142, goodwill is no longer amortized, but is subject to annual impairment tests. The Corporation tested goodwill for impairment as of December 31, 2003 and 2002. Based on these test results, the Corporation determined that there was no impairment of goodwill as of December 31, 2003 and 2002. Goodwill was $63.2 million at March 31, 2004 and $27.9 million at March 31, 2003. Goodwill increased due to the Caledonia acquisition. See Note G for further information about the Caledonia acquisition. Other The Corporation and its subsidiary banks are subject to certain legal actions arising in the ordinary course of business. In the opinion of management, after consultation with legal counsel, the ultimate disposition of these matters is not expected to have a material adverse effect on the consolidated income or financial position of the Corporation. NOTE B: LOANS AND NONPERFORMING ASSETS The following summarizes loans and nonperforming assets at the dates indicated (in thousands of dollars): March 31, December 31, March 31, Loans: Commercial $ 444,229 $ 405,929 $ 325,673 Real estate construction 148,592 138,280 106,384 Real estate commercial 640,292 628,815 506,243 Real estate residential 773,195 767,199 691,626 Consumer 542,811 541,052 501,767 Total Loans $2,549,119 $2,481,275 $2,131,693 Nonperforming Assets: Nonaccrual loans $ 5,317 $ 6,691 $ 5,730 Loans 90 days or more past due and still accruing interest 6,559 4,656 5,442 Total Nonperforming Loans 11,876 11,347 11,172 Repossessed assets acquired (1) 6,294 6,002 4,590 Total Nonperforming Assets $ 18,170 $ 17,349 $ 15,762 (1) Includes property acquired through foreclosure and by acceptance of a deed in lieu of foreclosure, and other property held for sale. CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES NOTE C: ALLOWANCE FOR LOAN LOSSES The following summarizes the changes in the allowance for loan losses (in thousands of dollars): Three Months Ended 2004 2003 Allowance for Loan Losses Balance as of January 1 $33,179 $30,672 Provision for loan losses 746 295 Gross loans charged off (945 ) (448 ) Gross recoveries of loans previously charged off 514 174 Net loans charged off (431 ) (274 ) Balance as of end of period $33,494 $30,693 The Corporation considers all nonaccrual commercial and commercial real estate loans to be impaired loans. Impaired loans as of March 31, 2004 and 2003 were $4.2 million and $3.9 million, respectively. The allowance for impaired loans was $1.9 million and $1.7 million as of March 31, 2004 and 2003, respectively. NOTE D: ACQUIRED INTANGIBLE ASSETS The following table sets forth the carrying amount, accumulated amortization and amortization expense of acquired intangible assets (in thousands): March 31, 2004 December 31, 2003 March 31, 2003 Carrying Accumulated Carrying Accumulated Carrying Accumulated Core Deposit Intangibles $8,991 $10,278 $9,496 $9,773 $9,445 $8,395 Other 732 133 793 72 146 29 Amortization expense for the: Quarter ended March 31, 2004 $ 566 Quarter ended March 31, 2003 462 Year ended December 31, 2003 1,883 CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES Estimated amortization expense for the years ending December 31: 2004 $2,272 2005 2,136 2006 1,938 2007 1,651 2008 1,292 NOTE E: STOCK OPTIONS The Corporation periodically grants stock options for a fixed number of shares with an exercise price equal to the market value of the shares on the date of grant. In accordance with Statement of Financial Accounting Standards No. 123, "Accounting for Stock-Based Compensation," the Corporation accounts for stock option grants under the provisions of Accounting Principles Board Opinion No. 25, "Accounting for Stock Issued to Employees" (APB 25). Under APB 25, because the exercise prices of the Corporation's stock options equal the market prices of the underlying stock at the dates of grant, no compensation expense is recognized at the date of grant. If the Corporation had elected to recognize compensation cost for options granted in the three months ended March 31, 2004 and 2003, based on the fair value of the options granted at the grant dates, net income and earnings per share would have been reduced to the pro forma amounts indicated below (in thousands, except per share amounts): 2004 2003 Net income - as reported $14,119 $14,014 Deduct: Total stock-based employee compensation expense determined under fair value based method for all awards, net of related tax effects (131 ) (63 ) Net income - pro forma $13,988 $13,951 Basic earnings per share - as reported $ .59 $ .59 Basic earnings per share - pro forma .59 .59 Diluted earnings per share - as reported .59 .59 Diluted earnings per share - pro forma .58 .59 CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES NOTE F: FINANCIAL GUARANTEES In the normal course of business, the Corporation is a party to financial instruments containing credit risk that are not required to be reflected in the consolidated statement of financial position. For the Corporation, these financial instruments are financial and performance standby letters of credit. The Corporation has risk management policies to identify, monitor and limit exposure to credit risk. To mitigate credit risk for these financial guarantees, the Corporation generally determines the need for specific covenant, guarantee and collateral requirements on a case-by-case basis, depending on the nature of the financial instrument and the customer's creditworthiness. At March 31, 2004, the Corporation had $15.8 million of outstanding financial and performance standby letters of credit. In 2003, the Financial Accounting Standards Board issued Interpretation No. 45, "Guarantor's Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others" ("FIN No. 45"), which requires additional disclosures by a guarantor about its obligations under certain guarantees that it has issued. FIN No. 45 also clarifies that a guarantor is required to recognize, at the inception of a guarantee, a liability for the fair value of the obligation undertaken in issuing the guarantee. The instruments impacted for the Corporation are financial and performance standby letters of credit. The accounting pronouncements of FIN No. 45 became effective for the Corporation on January 1, 2004, on a prospective basis. The impact of adoption was not material to the Corporation's consolidated results of operations, financial position or cash flows. NOTE G: OTHER The Corporation acquired Caledonia Financial Corporation ("Caledonia"), a one-bank holding company headquartered in Caledonia, Michigan, on December 1, 2003. As of that date, Caledonia had total assets of $211 million, net loans of $184 million, total deposits of $171 million and shareholders' equity of $22.3 million. Shareholders of Caledonia received $39.00 cash for each share of Caledonia common stock in a taxable transaction. The total value of the transaction was approximately $56.8 million, of which $52.3 million was paid in cash and $4.5 million represented the value of stock options yet to be paid as of the transaction date. The purchase price represented a premium over book value of $34.5 million. The Corporation will continue to operate Caledonia's bank subsidiary, State Bank of Caledonia, with branch offices in Caledonia, Dutton, Middleville and Kalamazoo, as a separate subsidiary until mid-2004. In the second quarter of 2004, the Corporation expects to restructure the State Bank of Caledonia into two of its other three bank subsidiaries. The branches in Caledonia, Middleville and Dutton are expected to become part of Chemical Bank West, headquartered in the Grand Rapids area, and the Kalamazoo branch is expected to become a part of Chemical Bank Shoreline, headquartered in Benton Harbor. CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES NOTE G: OTHER (continued) On September 30, 2003, the Corporation consolidated CFC Data Corp, its wholly-owned data processing subsidiary, into the parent. The data processing operations are primarily performed for the Corporation's bank subsidiaries. NOTE H: EMPLOYEE BENEFIT PLANS The components of net periodic benefit cost for the Corporation's qualified pension plan and non-qualified postretirement benefit plan are as follows: (in thousands) Defined Benefit Postretirement Three Months Ended March 31, 2004 2003 2004 2003 Service cost $ 1,086 $ 911 $ 7 $ 6 Interest cost 1,034 960 79 65 Expected return on plan assets (1,356 ) (1,243 ) - - Amortization of transition amount - (3 ) - - Amortization of prior service cost (9 ) (10 ) (81 ) (81 ) Amortization of unrecognized net (gain) loss 94 (1 ) 81 42 Net periodic benefit cost $ 849 $ 614 $ 86 $ 32 For further information on the Corporation's employee benefit plans, refer to Note H to the consolidated financial statements incorporated in the Corporation's Annual Report on Form 10-K for the year ended December 31, 2003. NOTE I: PENDING ACCOUNTING PRONOUNCEMENTS In January 2004, the Financial Accounting Standards Board ("FASB") issued a FASB Staff Position ("FSP"), "Accounting and Disclosure Requirements Related to the Medicare Prescription Drug, Improvement and Modernization Act of 2003," subsequently revised April 12, 2004. The FSP permits a sponsor of a postretirement health care plan that provides a prescription drug benefit to make a one-time election to defer accounting for the effects of the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (the "Act") and requires certain disclosures pending further consideration of the underlying accounting issues. The Act introduces a Medicare prescription drug benefit as well as a federal subsidy to sponsors of retiree health care benefit plans that provide a benefit that is at least actuarially equivalent to the Medicare benefit. The Corporation CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES NOTE I: PENDING ACCOUNTING PRONOUNCEMENTS (continued) is in the process of analyzing the impact the Act will have on its employee benefit plans. The FSP is effective for financial statements for interim or annual periods ending after December 7, 2003. If an entity elects deferral, that election may not be changed, and the deferral continues to apply until authoritative guidance in the accounting for the federal subsidy resulting from the Act is issued, or until a significant event occurs that would ordinarily call for remeasurement of a plan's assets and obligations (i.e. plan amendment, settlement or curtailment). The FASB plans to issue authoritative guidance on the accounting for subsidies in the second quarter of 2004, which could require the Corporation to modify its postretirement benefit disclosures. In accordance with the FSP, the Corporation elected to defer accounting for the effects of the Act. ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following is management's discussion and analysis of certain significant factors that have affected the Corporation's financial condition and results of operations during the periods included in the consolidated financial statements included in this filing. SUMMARY The Corporation's net income was $14.1 million in the first quarter of 2004, up .7% over net income of $14.0 million in the first quarter of 2003. Earnings per share was $.59 in the first quarter of both 2004 and 2003. Return on average assets in the first quarter of 2004 was 1.46%, compared to 1.59% in the first quarter of 2003. Return on average equity in the first quarter of 2004 was 12.3%, compared to 13.1% in the first quarter of 2003. Total assets were $3.91 billion as of March 31, 2004, up $202 million, or 5.4%, from total assets of $3.71 billion as of December 31, 2003, and up $297 million, or 8.2%, from total assets of $3.61 billion as of March 31, 2003. The increase in total assets from December 31, 2003 was primarily due to investing $150 million of new FHLB borrowings in mortgage-backed securities. See the following "Balance Sheet Changes" section for additional information. The increase in total assets from March 31, 2003 was primarily due to the acquisition of Caledonia, which added $211 million in total assets as well as the previously mentioned purchase of mortgage-backed securities. Total loans increased $68 million, or 2.7%, from December 31, 2003, and $417 million, or 19.6%, from March 31, 2003 to $2.55 billion as of March 31, 2004. The increase in total loans was primarily due to growth in residential and commercial real estate loans. During 2003, the Corporation held in its portfolio the majority of its fixed-rate residential real estate loan originations with maturities of fifteen years versus selling all of these loans in the secondary market. The growth in residential real estate loans was undertaken to achieve the Corporation's desired mix of residential loans to total loans and to partially offset the negative impact of a lower net interest margin. The increase in commercial real estate loans was due to increased emphasis by the Corporation on growing these loans in the Corporation's community bank market areas. The increase in total loans was also due to the Caledonia acquisition on December 1, 2003, which added $184 million in loans. Shareholders' equity increased $32.8 million, or 7.5%, from March 31, 2003 to $469.8 million as of March 31, 2004, or $19.63 per share, representing 12.0% of total assets. The increase was primarily attributable to retained net income. RESULTS OF OPERATIONS Net Interest Income The Corporation's net interest income in the first quarter of 2004 was $36.8 million, a $1.7 million, or 4.8%, increase from the $35.1 million recorded in the first quarter of 2003. The increase was primarily due to higher average interest-earning assets. Both the purchase of Caledonia in December 2003 and the $150 million purchase of mortgage-backed securities in January 2004 were the primary factors that increased net interest income in the quarter ended March 31, 2004 compared to the first
Washington, D.C. 20549
FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2004, OR
FOR THE TRANSITION PERIOD FROM ____________ TO ____________
(Exact Name of Registrant as Specified in its Charter)
(State or Other Jurisdiction
of Incorporation or Organization)
(I.R.S. Employer
Identification No.)
Midland, Michigan
(Address of Principal Executive Offices)
48640
(Zip Code)
(Registrant's Telephone Number, Including Area Code)
CHEMICAL FINANCIAL CORPORATION
FORM 10-Q
Statement of Financial Position as of December 31, 2003)
4
March 31, 2004 and March 31, 2003
4
December 31, 2003 and March 31, 2003
5
March 31, 2004 and March 31, 2003
6
Results of Operations
16-22
of Equity Securities
24
Consolidated Statements of Income (Unaudited)
March 31
Consolidated Statements of Financial Position (In thousands)
2004
2003
2003
3/31/04, $197,983 at 12/31/03 and $283,742 at 3/31/03)
169,742
193,363
276,367
Consolidated Statements of Cash Flows (Unaudited)
March 31
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
March 31, 2004
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
March 31, 2004
March 31
March 31
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
March 31, 2004
2004
2003
2003
at 3/31/04, $5,777 at 12/31/03, $9,391 at
3/31/03)
$10,271
$10,728
$17,442
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
March 31, 2004
2004
2003
2003
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
March 31, 2004
March 31
Amount
Amortization
Amount
Amortization
Amount
Amortization
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
March 31, 2004
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
March 31, 2004
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
March 31, 2004
Pension Plan
Benefit Plan
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
March 31, 2004
quarter of 2003. This increase was partially offset by a lower net interest margin. Net interest margin decreased to 4.12% in the first quarter of 2004 from 4.25% in the first quarter of 2003.
Provision for Loan Losses
The provision for loan losses ("provision") is the amount added to the allowance for loan losses ("allowance") to absorb loan losses in the loan portfolio. The allowance provides for probable losses that have been identified with specific customer relationships and for probable losses believed to be inherent in the remainder of the loan portfolio but that have not been specifically identified. The allowance is comprised of specific allowances (assessed for loans that have known credit weaknesses), general allowances based on an assigned risk rating and an unallocated allowance for imprecision in the subjective nature of the specific and general allowance methodology. Management continuously evaluates the allowance to ensure the level is adequate to absorb losses inherent in the loan portfolio. This evaluation is based on a continuous review of the loan portfolio, both individually and by category, and includes consideration of changes in the mix and volume of the loan portfolio, actual loan loss experienc e, the financial condition of the borrowers, industry and geographical exposures within the portfolio, economic conditions and employment levels of the Corporation's local markets, and other factors affecting business sectors. A formal evaluation of the allowance is prepared quarterly to assess the risk in the loan portfolio and to determine the adequacy of the allowance. The Corporation's loan review personnel, who are independent of the loan origination function, review this evaluation.
The provision for loan losses was $.75 million in the first quarter of 2004 compared to $.30 million in the first quarter of 2003. Net loan losses were $.43 million in the first quarter of 2004 compared to $.27 million in the first quarter of 2003.
Noninterest Income
Noninterest income increased $.65 million, or 7.0%, in the first quarter of 2004, compared to the first quarter of 2003. The increase was primarily due to increases in investment securities gains of $.8 million. The increase in gains on investment securities was primarily due to the sale of the majority of the Corporation's equity securities portfolio. Service charge income also increased $.7 million during the March 31, 2004 quarter compared to the March 31, 2003 quarter. These noninterest income increases were partially offset by a decrease in mortgage banking revenue of $.8 million. Mortgage banking sales volume was significantly lower during the first quarter of 2004 compared to the first quarter of 2003. The decrease in loans sold was primarily due to a decrease in loan refinance activity.
Operating Expenses
Total operating expenses increased $2.1 million, or 9.3%, in the first quarter of 2004, compared to the first quarter of 2003. The increase in operating expenses attributable to the acquisition of Caledonia of approximately $1.1 million represented slightly over one-half of the increase. Operating expenses also increased due to higher equipment expense related to technology enhancements and higher employee benefit costs.
Income Tax Expense
The Corporation's effective federal income tax rate was 32.4% in the first quarter of 2004, compared to 33.6% in the first quarter of 2003. The difference between the federal statutory income tax rate and the Corporation's effective federal income tax rate primarily is a function of the proportion of the Corporation's interest income exempt from federal taxation, nondeductible interest expense and other nondeductible expenses. In addition, the Corporation utilized a $.53 million capital loss carryover during the first quarter of 2004, which reduced federal income tax expense.
BALANCE SHEET CHANGES
Asset and Deposit Changes
Total assets increased $202 million, or 5.4%, from December 31, 2003 and increased $297 million, or 8.2%, from March 31, 2003 to $3.91 billion as of March 31, 2004. Total deposits increased $50.4 million, or 1.7%, from December 31, 2003, and increased $113.5 million, or 3.9%, from March 31, 2003 to $3.02 billion as of March 31, 2004. The increase in total assets from December 31, 2003 was primarily due to investing $150 million of new FHLB borrowings in mortgage-backed securities. The increase in total assets from March 31, 2003 was primarily due to the acquisition of Caledonia, which added $211 million in total assets, as well as the previously mentioned purchase of mortgage-backed securities.
Investment Securities
Total investment securities increased $88.8 million, or 9.6%, from December 31, 2003 and decreased $212.4 million, or 17.4%, from March 31, 2003. The increase in investment securities from December 31, 2003 was primarily due to investing $150 million of new FHLB borrowings in seven-year balloon loan mortgage-backed securities. This increase was partially offset by a decrease in U.S. Treasury and agency securities of $60.2 million. The proceeds from the U.S. Treasury and agency securities sales and maturities were utilized to fund loan growth. The decrease in investment securities from March 31, 2003 was primarily due to sales and maturities, which were utilized to fund loan growth.
Loans
The Corporation's philosophy is such that it will not compromise on loan quality and generally does not make loans outside its banking markets to increase its loan portfolio. In addition, the Corporation generally does not participate in syndicated loans, which is a method utilized by many financial institutions to increase the size of their loan portfolios. The Corporation's loan portfolio is generally diversified geographically, as well as along industry lines and, therefore, the Corporation believes that its loan portfolio is reasonably sheltered from material adverse local economic impact.
Total loans as of March 31, 2004 were $2.55 billion, compared to $2.48 billion as of December 31, 2003 and $2.13 billion as of March 31, 2003.
Residential real estate loans increased $6.0 million, or .8%, from December 31, 2003 and $81.6 million, or 11.8%, from March 31, 2003 to $773.2 million as of March 31, 2004. Residential real estate loans represented 30.4%, 30.9% and 32.4 % of the Corporation's loan portfolio as of March 31, 2004, December 31, 2003 and March 31, 2003, respectively. The Corporation's residential real
Real estate construction loans increased $10.3 million, or 7.5%, from December 31, 2003 and $42.2 million, or 39.7%, from March 31, 2003 to $148.6 million as of March 31, 2004. The increase from March 31, 2003 was primarily due to the Caledonia acquisition. Real estate construction loans represented 5.8%, 5.6% and 5.0% of the Corporation's loan portfolio as of March 31, 2004, December 31, 2003 and March 31, 2003, respectively. Construction lending is generally considered to involve a higher degree of risk than one- to four-family residential lending because of the uncertainties of construction, including the possibility of costs exceeding the initial estimates and the need to obtain a tenant or purchaser of the property if it will not be owner-occupied. The Corporation generally attempts to mitigate the risks associated with construction lending by, among other things, lending primarily in its market area, using conservative underwriting guidelines, and closely monitoring the construction process.
Commercial loans increased $38.3 million, or 9.4%, from December 31, 2003, and $118.6 million, or 36.4%, from March 31, 2003 to $444.2 million as of March 31, 2004. The increase in commercial loans from December 31, 2003 was due to across the board growth at each of the Corporation's subsidiary banks. The increase in commercial loans from March 31, 2003 was primarily due to the Caledonia acquisition and the previously mentioned growth at each of the Corporation's subsidiary banks. Commercial loans represented 17.4%, 16.4% and 15.3% of the Corporation's loan portfolio as of March 31, 2004, December 31, 2003 and March 31, 2003, respectively.
Commercial real estate loans increased $11.5 million, or 1.8%, from December 31, 2003 and $134 million, or 26.5%, from March 31, 2003 to $640.3 million as of March 31, 2004. The increase in commercial loans from March 31, 2003 was primarily due to the Caledonia acquisition and due to placing greater emphasis on growing these loans in the Corporation's community bank market areas. Commercial real estate loans represented 25.1%, 25.3% and 23.8% of the Corporation's loan portfolio as of March 31, 2004, December 31, 2003 and March 31, 2003, respectively.
Commercial lending and commercial real estate lending are generally considered to involve a higher degree of risk than one- to four-family residential lending. Such lending typically involves large loan balances concentrated in a single borrower for rental or business properties or for the operation of a business. In addition, the payment experience on loans secured by income-producing properties is typically dependent on the success of the operation of the related project and thus is typically affected by adverse conditions in the real estate market and in the economy. The Corporation generally attempts to mitigate the risks associated with commercial lending by, among other things, lending primarily in its market area and using conservative loan-to-value ratios in the underwriting process.
Consumer loans increased $1.8 million, or .3%, from December 31, 2003, and increased $41 million, or 8.2%, from March 31, 2003 to $542.8 million as of March 31, 2004. Consumer loans represented 21.3%, 21.8% and 23.5% of total loans as of March 31, 2004, December 31, 2003 and March 31, 2003, respectively.
Consumer loans generally have shorter terms than mortgage loans but generally involve more credit risk than one- to four-family residential lending because of the type and nature of the collateral. Collateral values, particularly those of automobiles, are negatively impacted by many factors, such
The Corporation's total loan to deposit ratio as of March 31, 2004, December 31, 2003 and March 31, 2003 was 84.5%, 83.6% and 73.4%, respectively.
Nonperforming loans consist of loans which are past due for principal or interest payments by 90 days or more and are still accruing interest, loans for which the accrual of interest has been discontinued, and other loans which have been restructured to less than market terms due to a serious weakening of the borrower's financial condition. Nonperforming loans were $11.9 million as of March 31, 2004, $11.3 million as of December 31, 2003 and $11.2 million as of March 31, 2003, and represented .47%, .46% and .52% of total loans, respectively. The increase in nonperforming loans since December 31, 2003 was primarily due to additional commercial real estate loans in the greater than ninety days past due and still accruing category.
A loan is considered impaired when management determines it is probable that all of the principal and interest due under the contractual terms of the loan will not be collected. In most instances, the impairment is measured based on the fair market value of the underlying collateral. Impairment may also be measured based on the present value of expected future cash flows discounted at the loan's effective interest rate. A portion of the allowance for loan losses may be allocated to impaired loans. The Corporation has taken the position that all nonaccrual commercial and commercial real estate loans are considered impaired loans.
Impaired loans totaled $4.2 million as of March 31, 2004, $5.5 million as of December 31, 2003 and $3.9 million as of March 31, 2003. After analyzing the various components of the customer relationships and evaluating the underlying collateral of impaired loans, the allowance for loan losses allocated to impaired loans was as follows: $1.9 million as of March 31, 2004, $2.4 million as of December 31, 2003 and $1.7 million as of March 31, 2003. The process of measuring impaired loans and the allocation of the allowance for loan losses requires judgment and estimation. The eventual outcome may differ from the estimates used on these loans.
The allowance for loan losses at March 31, 2004 was $33.5 million and represented 1.31% of total loans, compared to $33.2 million, or 1.34% of total loans at December 31, 2003 and $30.7 million, or 1.44% of total loans at March 31, 2003.
Liquidity
The maintenance of an adequate level of liquidity is necessary to ensure that sufficient funds are available to meet customers' loan demands and deposit withdrawals and to capitalize on opportunities for business expansion. The banking subsidiaries' primary liquidity sources consist of investment securities, those maturing within one year and those classified as available for sale, loan payments, FHLB advances and federal funds sold.
The Corporation has contractual obligations that require future cash payments. The most significant of these is FHLB borrowings. The following table shows scheduled principal reductions on FHLB advances (in thousands):
|
April 1, 2004 - December 31, 2004 |
$ |
17,000 |
|
|
2005 |
|
122,390 |
|
|
2006 |
|
69,687 |
|
|
2007 |
|
10,000 |
|
|
2008 |
|
30,000 |
|
|
Thereafter |
|
43,133 |
|
|
Total |
$ |
292,210 |
|
The Corporation increased its FHLB borrowings in January 2004 by $150 million. These borrowings primarily mature in 2005 and 2006. The Corporation's intention is to use existing investment security maturities to repay this 2004 borrowing.
The FHLB borrowings are collateralized by a blanket lien on qualified one-to four-family residential mortgage loans. The carrying value of these mortgage loans was $701 million, which represented a total borrowing capacity based on existing collateral of $483 million as of March 31, 2004. Therefore, the Corporation's additional borrowing availability through the FHLB at March 31, 2004 under the blanket lien agreement was $191 million. The Corporation has the option to pledge additional qualified loans and investment securities to create additional borrowing availability with the FHLB.
The Corporation has various commitments that may impact liquidity. The following table summarizes the Corporation's commitments and expected expiration dates by period at March 31, 2004. Since many of these commitments historically have expired without being drawn upon, the total amount of these commitments does not necessarily represent future cash requirements of the Corporation.
Commitments (in thousands)
|
Expected Expiration Dates by Period |
||||||||
|
|
|
|
|
|
|
More |
|
|
Unused commitments to extend credit |
$224,967 |
|
$21,483 |
|
$60,488 |
|
$22,206 |
|
$329,144 |
Undisbursed loans |
108,136 |
|
- |
|
- |
|
- |
|
108,136 |
Standby letters of credit and financial guarantees |
10,498 |
|
3,283 |
|
1,046 |
|
930 |
|
15,757 |
Total commitments |
$343,601 |
|
$24,766 |
|
$61,534 |
|
$23,136 |
|
$453,037 |
Capital Resources
As of March 31, 2004, shareholders' equity was $469.8 million, compared to $458.0 million as of December 31, 2003 and $437.0 million as of March 31, 2003, resulting in an increase of $11.7 million, or 2.6%, from December 31, 2003 and $32.8 million, or 7.5%, from March 31, 2003. Shareholders' equity as a percentage of total assets was 12.0% as of March 31, 2004, 12.4% as of December 31, 2003 and 12.1% as of March 31, 2003.
A statement of changes in shareholders' equity covering the three-month periods ended March 31, 2004 and March 31, 2003 follows (in thousands):
|
Three Months Ended |
|
||
|
2004 |
|
2003 |
|
Total shareholders' equity as of January 1 |
$458,049 |
|
$430,339 |
|
Comprehensive income: |
|
|
|
|
Net income |
14,119 |
|
14,014 |
|
Change in unrealized net gains on securities |
|
|
|
|
available for sale, net of tax |
(457 |
) |
(1,343 |
) |
Total comprehensive income |
13,662 |
|
12,671 |
|
Cash dividends paid |
(6,338 |
) |
(5,925 |
) |
Shares issued from stock option and other plans |
4,424 |
|
451 |
|
Repurchase of shares |
- |
|
(496 |
) |
Total shareholders' equity as of end of period |
$469,797 |
|
$437,040 |
|
The following table represents the Corporation's regulatory capital ratios as of March 31, 2004:
|
|
|
Tier 1 |
|
Total |
|
|
|
|
|
|
|
|
Chemical Financial Corporation-actual ratio |
10.1 |
% |
15.3 |
% |
16.5 |
% |
Regulatory minimum ratio |
3.0 |
|
4.0 |
|
8.0 |
|
Ratio considered "well capitalized" by |
|
|
|
|
|
|
The Corporation's Tier 1 and Total capital ratios under the risk-based capital measure at March 31, 2004 exceed the regulatory agencies ratios to be considered "well capitalized" partially due to the Corporation holding $272 million in investment securities and other assets which are assigned a 0% risk rating; $858 million in assets, primarily investment securities, which are assigned a 20% risk rating; and $897 million in residential real estate mortgages and other assets which are assigned a 50% risk rating. These three risk ratings (0%, 20% and 50%) represented 50.6% of the Corporation's total risk-based assets (including off-balance sheet items) as of March 31, 2004.
The following table shows stock repurchase activity by the Corporation during the periods indicated:
|
Three Months Ended March 31 |
|
|||
|
2004 |
|
2003 |
|
|
Number of shares repurchased |
- |
|
18,000 |
|
|
Average price of shares repurchased |
- |
|
$27.53 |
|
|
The Corporation's latest stock repurchase program allows for the repurchase of up to 441,000 shares, of which 361,779 shares were available for future repurchase at March 31, 2004.
ITEM 3. |
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK |
The information concerning quantitative and qualitative disclosures about market risk contained in the discussion regarding interest rate risk and sensitivity under the caption "Liquidity Risk"and "Interest Rate Risk" on pages 17 through 21 of the Corporation's Annual Report to Shareholders for the year ended December 31, 2003 is here incorporated by reference. Such Annual Report was previously filed as Exhibit 13 to the Corporation's Annual Report on Form 10-K for the year ended December 31, 2003.
The Corporation does not believe that there has been a material change in the nature or categories of the Corporation's primary market risk exposure, or the particular markets that present the primary risk of loss to the Corporation. As of the date of this report, the Corporation does not know of or expect there to be any material change in the general nature of its primary market risk exposure in the near term. The methods by which the Corporation manages its primary market risk exposure, as described in the sections of its Annual Report to Shareholders incorporated by reference in response to this item, have not changed materially during the current year. As of the date of this report, the Corporation does not expect to make material changes in those methods in the near term. The Corporation may change those methods in the future to adapt to changes in circumstances or to implement new techniques.
The Corporation's market risk exposure is mainly comprised of its vulnerability to interest rate risk. Prevailing interest rates and interest rate relationships are primarily determined by market factors that are beyond the Corporation's control. All information provided in response to this item consists of forward-looking statements. Reference is made to the section captioned "Forward-Looking Statements" in this report for a discussion of the limitations on the Corporation's responsibility for such statements. In this discussion, "near term" means a period of one year following the date of the most recent consolidated statement of financial position contained in this report.
ITEM 4. |
CONTROLS AND PROCEDURES |
An evaluation was performed under the supervision and with the participation of the Corporation's management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Corporation's disclosure controls and procedures. Based on and as of the time of that evaluation, the Corporation's management, including the Chief Executive Officer and Chief Financial Officer, concluded that the Corporation's disclosure controls and procedures were effective as of the end of the period covered by this report. There was no change in the Corporation's internal control over financial reporting that occurred during the three months ended March 31, 2004 that has materially affected, or that is reasonably likely to materially affect, the Corporation's internal control over financial reporting.
PART II. OTHER INFORMATION
ITEM 2. |
CHANGES IN SECURITIES, USE OF PROCEEDS AND ISSUER PURCHASES OF EQUITY SECURITIES |
  The Corporation did not repurchase any shares of its common stock during the period covered by this report.
ITEM 6. |
EXHIBITS AND REPORTS ON FORM 8-K |
(a) |
Exhibits. The following exhibits are filed as part of this report on Form 10-Q: |
|||
|
|
|
|
|
|
Exhibit |
|
|
|
|
|
|
|
|
|
3.1 |
|
Restated Articles of Incorporation. Previously filed as Exhibit 4.1 to the Corporation's Registration Statement on Form S-8 filed with the Commission on March 2, 2001. Here incorporated by reference. |
|
|
|
|
|
|
|
3.2 |
|
Bylaws. Previously filed as Exhibit 3.2 to the Corporation's Annual Report on Form 10-K for the year ended December 31, 2001. Here incorporated by reference. |
|
|
|
|
|
|
|
31.1 |
|
Certification. Certification of President and Chief Executive Officer under Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
|
|
|
|
|
31.2 |
|
Certification. Certification of Executive Vice President, Chief Financial Officer and Treasurer under Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
|
|
|
|
|
32.1 |
|
Certification pursuant to 18 U.S.C. § 1350. |
(b) |
Reports on Form 8-K. During the three-month period ended March 31, 2004, the following report was filed on Form 8-K: |
|
Date |
Item Reported |
Financial Statements |
|
|
January 20, 2004 |
7(c), 9 |
None |
|
|
|
|
|
|
|
|
|
|
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
CHEMICAL FINANCIAL CORPORATION |
|
|
Date: May 6, 2004 |
By: /s/ David B. Ramaker |
|
David B. Ramaker |
|
|
|
|
Date: May 6, 2004 |
By: /s/ Lori A. Gwizdala |
|
Lori A. Gwizdala |
EXHIBIT INDEX
Exhibit |
|
|
|
|
|
3.1 |
|
Restated Articles of Incorporation. Previously filed as Exhibit 4.1 to the Corporation's Registration Statement on Form S-8 filed with the Commission on March 2, 2001. Here incorporated by reference. |
|
|
|
3.2 |
|
Bylaws. Previously filed as Exhibit 3.2 to the Corporation's Annual Report on Form 10-K for the year ended December 31, 2001. Here incorporated by reference. |
|
|
|
31.1 |
|
Certification. Certification of President and Chief Executive Officer under Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
|
31.2 |
|
Certification. Certification of Executive Vice President, Chief Financial Officer and Treasurer under Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
|
32.1 |
|
Certification pursuant to 18 U.S.C. § 1350. |
EXHIBIT 31.1
CERTIFICATIONS
I, David B. Ramaker, certify that:
1. |
I have reviewed this quarterly report on Form 10-Q of Chemical Financial Corporation; |
|
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
|
4. |
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: |
|
a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
|
|
|
b) |
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
|
|
|
c) |
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
5. |
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): |
|
a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
|
|
|
|
b) |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
Date: May 6, 2004
/s/ David B. Ramaker |
|
David B. Ramaker |
|
EXHIBIT 31.2
CERTIFICATIONS
I, Lori A. Gwizdala, certify that:
1. |
I have reviewed this quarterly report on Form 10-Q of Chemical Financial Corporation; |
|
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
|
4. |
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: |
|
a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
|
|
|
b) |
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
|
|
|
c) |
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
5. |
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): |
|
a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
|
|
|
|
b) |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
Date: May 6, 2004
/s/ Lori A. Gwizdala |
|
Lori A. Gwizdala |
|
EXHIBIT 32.1
CERTIFICATION
Pursuant to 18 U.S.C. § 1350, each of the undersigned hereby certifies in his or her capacity as an officer of Chemical Financial Corporation (the "Company") that the Quarterly Report of the Company on Form 10-Q for the quarter ended March 31, 2004 fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that the information contained in such report fairly presents, in all material respects, the financial condition of the Company at the end of such period and the results of operations of the Company for such period.
Dated: May 6, 2004 |
/s/ David B. Ramaker |
|
David B. Ramaker |
|
|
|
|
|
|
Dated: May 6, 2004 |
/s/ Lori A. Gwizdala |
|
Lori A. Gwizdala |